Cytomegalovirus retinitis treated with valganciclovir in Wegener’s granulomatosis
Clinical Ophthalmology, 03/30/2012Kabata Y et al.
A 68–year–old male patient with anti–proteinase–3 ANCA–positive Wegener’s granulomatosis who was receiving immunosuppressive therapy with methylprednisolone, cyclophosphamide, and azathioprine developed cytomegalovirus (CMV) retinitis. The patient received intravenous ganciclovir as induction therapy and oral valganciclovir as maintenance therapy. Oral valganciclovir is convenient and effective for the management of CMV retinitis in the patient with Wegener’s granulomatosis.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.